Skip to main content


Page 6 of 304

  1. To explore the characteristics of renal artery variation in patients with renal cell carcinoma and to evaluate the predicting value of accessory renal artery in the pathological grading of renal cell carcinoma.

    Authors: Dingyang Lv, Huiyu Zhou, Fan Cui, Jie Wen and Weibing Shuang
    Citation: BMC Cancer 2023 23:274
  2. Stereotactic radiosurgery (SRS) is a frequently chosen treatment for patients with brain metastases and the number of long-term survivors is increasing. Brain necrosis (e.g. radionecrosis) is the most importan...

    Authors: J. A. Crouzen, A. L. Petoukhova, M. L. D. Broekman, M. Fiocco, U. J. Fisscher, J. H. Franssen, C. G. M. Gadellaa-van Hooijdonk, M. Kerkhof, M. Kiderlen, M. E. Mast, C. M. van Rij, R. Nandoe Tewarie, M. A. E. van de Sande, P. P. G. van der Toorn, R. Vlasman, M. J. Vos…
    Citation: BMC Cancer 2023 23:273
  3. Ewing sarcoma has attracted more attention in recent years but has yet to be bibliometrically analyzed. Hence, this study investigated the trend of Ewing sarcoma over the past 30 years with bibliometric analysis.

    Authors: Guangtao Han, Ting Liu and Pengde Kang
    Citation: BMC Cancer 2023 23:272
  4. To evaluate the effectiveness of an innovative supervised exercise programme to mitigate the loss of lean body mass, functional capacity and quality of life in people with head and neck cancer, as well as to i...

    Authors: M. Rodriguez-Arietaleanizbeaskoa, E Mojas Ereño, MS Arietaleanizbeaskoa, G. Grandes, A Rodríguez Sánchez, V. Urquijo, I Hernando Alday, M. Dublang, G. Angulo-Garay and J. Cacicedo
    Citation: BMC Cancer 2023 23:271
  5. Since renal cell carcinoma(RCC) is insensitive to conventional chemoradiotherapy, molecularly targeted drugs are commonly used treatments for unresectable advanced RCC. The aim of this study was to explore the...

    Authors: Haohao Lu, Qing Ye, Chuansheng Zheng, Li Fan and Xiangwen Xia
    Citation: BMC Cancer 2023 23:270
  6. To investigate how the negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cell lines and prognosis in postoperative breast cancer patients.

    Authors: Fang Xin Jian, Peng Xiao Bao, Wang Fu Li, Yan Hai Cui and Hang Guan Hong
    Citation: BMC Cancer 2023 23:269
  7. Prostate cancer patients with locoregional lymph node disease at diagnosis (N1M0) still have a limited prognosis despite the improvements provided by aggressive curative intent multimodal locoregional external...

    Authors: Esmée C. A. van der Sar, Arthur J. A. T. Braat, Jochem R. N. van der Voort- van Zyp, Betty S. van der Veen, Pim J. van Leeuwen, Daphne M. V. de Vries-Huizing, Jeroen M. A. Hendrikx, Marnix G. E. H. Lam and Wouter V. Vogel
    Citation: BMC Cancer 2023 23:268
  8. Small intestinal neuroendocrine tumors (SI-NET) are highly differentiated and genetically stable malignant tumors, yet they often present with advanced metastatic spread at the time of diagnosis. In contrast t...

    Authors: Bilal Almobarak, Vishal Amlani, Linda Inge, Tobias Hofving, Andreas Muth, Ola Nilsson, Martin Johansson, Yvonne Arvidsson and Erik Elias
    Citation: BMC Cancer 2023 23:267
  9. Our previous studies have identified CA916798 as a chemotherapy resistance-associated gene in lung cancer. However, the histopathological relevance and biological function of CA916798 in lung adenocarcinoma (L...

    Authors: Jian He, Xi Lan, Xiayan Liu, Caixia Deng, Hu Luo, Yan Wang, Ping Kang, Zhijian Sun, Lintao Zhao and Xiangdong Zhou
    Citation: BMC Cancer 2023 23:266
  10. COVID-19 particularly impacted patients with co-morbid conditions, including cancer. Patients with melanoma have not been specifically studied in large numbers. Here, we sought to identify factors that associa...

    Authors: Douglas B. Johnson, Michael B. Atkins, Cassandra Hennessy, Trisha Wise-Draper, Hannah Heilman, Joy Awosika, Ziad Bakouny, Chris Labaki, Renee Maria Saliby, Clara Hwang, Sunny R. K. Singh, Nino Balanchivadze, Christopher R. Friese, Leslie A. Fecher, James J. Yoon, Brandon Hayes-Lattin…
    Citation: BMC Cancer 2023 23:265
  11. The outcomes of patients with clear cell renal cell carcinoma (ccRCC) were dreadful due to lethal local recurrence and distant metastases. Accumulating evidence suggested that ccRCC was considered a metabolic ...

    Authors: Diaoyi Tan, Daojia Miao, Chuanyi Zhao, Jian Shi, Qingyang Lv, Zhiyong Xiong, Hongmei Yang and Xiaoping Zhang
    Citation: BMC Cancer 2023 23:264
  12. Zinc finger and BTB domain-containing protein 4 (ZBTB4) belongs to the zinc finger protein family, which has a role in regulating epigenetic inheritance and is associated with cell differentiation and prolifer...

    Authors: Zhe Yang, Feiran Chen, Feng Wang, Xiubing Chen, Biaolin Zheng, Xiaomin Liao, Zhejun Deng, Xianxian Ruan, Jing Ning, Qing Li, Haixing Jiang and Shanyu Qin
    Citation: BMC Cancer 2023 23:263
  13. Primary brain tumor (PBT) patients experience higher levels of distress and anxiety than other solid tumor patients, particularly at the time of clinical evaluation when uncertainty about disease status is hig...

    Authors: Amanda L. King, Alvina A. Acquaye-Mallory, Elizabeth Vera, Tito Mendoza, Jennifer Reyes, Macy L. Stockdill, Mark R. Gilbert and Terri S. Armstrong
    Citation: BMC Cancer 2023 23:262
  14. To develop and validate predictive models using clinical parameters, radiomic features and a combination of both for preoperative differentiation of pulmonary nodular mucinous adenocarcinoma (PNMA) from pulmon...

    Authors: Junjie Zhang, Ligang Hao, MingWei Qi, Qian Xu, Ning Zhang, Hui Feng and Gaofeng Shi
    Citation: BMC Cancer 2023 23:261
  15. Circulating tumour DNA (ctDNA) to detect minimal residual disease (MRD) is emerging as a biomarker to predict recurrence in patients with curatively treated early stage colorectal cancer (CRC). ctDNA risk stra...

    Authors: Susanna Slater, Annette Bryant, Hsiang-Chi Chen, Ruwaida Begum, Isma Rana, Maria Aresu, Clare Peckitt, Oleg Zhitkov, Retchel Lazaro-Alcausi, Victoria Borja, Rachel Powell, David Lowery, Michael Hubank, Thereasa Rich, Gayathri Anandappa, Ian Chau…
    Citation: BMC Cancer 2023 23:257
  16. Currently, the association between smoking, alcohol, and coffee intake and the risk of ovarian cancer (OC) remains conflicting. In this study, we used a two-sample mendelian randomization (MR) method to evalua...

    Authors: Sicong Liu, Songwei Feng, Furong Du, Ke Zhang and Yang Shen
    Citation: BMC Cancer 2023 23:256
  17. Little is known about DNMT3A expression and its prognostic significance in childhood B cell acute lymphoblastic leukemia (B-ALL).

    Authors: Weijing Li, Shuguang Liu, Chanjuan Wang, Lei Cui, Xiaoxi Zhao, Wei Liu, Ruidong Zhang and Zhigang Li
    Citation: BMC Cancer 2023 23:255

    The Correction to this article has been published in BMC Cancer 2023 23:366

  18. The role of neutrophil–lymphocyte ratio (NLR) as a predictor for survival in single fraction SBRT-treated non-small cell lung cancer (NSCLC) patients remains unclear. We performed an observational cohort study...

    Authors: Karen Huang, Sharan Prasad, Sung Jun Ma, Han Yu, Austin J. Iovoli, Mark K. Farrugia, Elizabeth U. Dexter, Todd L. Demmy, Nadia K. Malik and Anurag K. Singh
    Citation: BMC Cancer 2023 23:254
  19. Difficulties in cancer services access increase the burden of disease and mortality in rural areas, and telehealth can be a useful tool to address these inequalities.

    Authors: Juan Guillermo Restrepo, Juliana Alarcón, Andrés Hernández, Saveria Sangiovanni, Sofía González, Kelly Gallego, Evelyn E. Peña-Zárate, Laura Libreros-Peña and María Fernanda Escobar
    Citation: BMC Cancer 2023 23:253
  20. A few studies have reported the distribution of the microbiota in breast cancer tissues, but few reports have compared the microbiota in different subtypes of breast cancer tissue. Moreover, no study has repor...

    Authors: Enuo Liu, Fan Zhang, Tiansheng Xu, Luyi Ye, Sean Si Qian Ma and Zai-Si Ji
    Citation: BMC Cancer 2023 23:252
  21. Currently there are no established fertility preservation options for pre-pubertal boys facing cancer treatment. Granulocyte-colony stimulating factor (G-CSF) treatment has been proposed to be chemoprotective ...

    Authors: Gabriele Matilionyte, Grace Forsyth, Jingtao Guo, Michael P. Rimmer, Brian P. Hermann, Richard A. Anderson and Rod T. Mitchell
    Citation: BMC Cancer 2023 23:251
  22. We aimed to investigate associations between pre-diagnostic anti-Epstein-Barr virus (EBV) antibodies, including interactions with hepatitis B virus (HBV), and risk of primary liver cancer in southern China.

    Authors: Yun Du, Xia Yu, Ellen T. Chang, Shifeng Lian, Biaohua Wu, Fugui Li, Bing Chu, Kuangrong Wei, Jiyun Zhan, Xuejun Liang, Weimin Ye and Mingfang Ji
    Citation: BMC Cancer 2023 23:250
  23. The failure rate after neoadjuvant chemoradiotherapy followed by surgery is approximately 34.6%–48% for resectable esophageal carcinoma. Pathologic complete response after neoadjuvant chemoradiotherapy is an i...

    Authors: Jinsong Yang, Ai Huang, Kunyu Yang and Ke Jiang
    Citation: BMC Cancer 2023 23:249
  24. The prognostic impact of EGFR mutation as major targetable somatic gene variant on lung adenocarcinoma is controversial. KRAS is another major somatic variant in lung adenocarcinoma, and a therapeutic agent for K...

    Authors: Masaoki Ito, Yoshihiro Miyata, Kei Kushitani, Daisuke Ueda, Yukio Takeshima and Morihito Okada
    Citation: BMC Cancer 2023 23:248
  25. This study was designed to investigate the impact of age on the effectiveness and immune-related adverse events (irAEs) of programmed death-(ligand)1 [PD-(L)1] inhibitors in patients with non-small cell lung c...

    Authors: Hanieh Abedian Kalkhoran, Juliëtte Zwaveling, Bert N. Storm, Sylvia A. van Laar, Johanneke EA Portielje, Henk Codrington, Dieuwke Luijten, Pepijn Brocken, Egbert F. Smit and Loes E. Visser
    Citation: BMC Cancer 2023 23:247
  26. The purpose of this study was to explore the short-term efficacy and safety of neoadjuvant chemotherapy combined with arterial chemoembolization for locally advanced gastric cancer (LAGC).

    Authors: Jianguo Yang, Juncai Li, Qican Deng, Zhenzhou Chen, Kuan He, Yajun Chen and Zhongxue Fu
    Citation: BMC Cancer 2023 23:246
  27. To investigate the role of platelet-to-lymphocyte ratio (PLR) in complete pathological response (pCR) of breast cancer (BC) patients after neoadjuvant chemotherapy (NAC), as well as to establish and validate a...

    Authors: Rulan Ma, Wanzhen Wei, Haixia Ye, Chengxue Dang, Kang Li and Dawei Yuan
    Citation: BMC Cancer 2023 23:245
  28. Liver cancer is the third most deadly malignant tumor in the world with poor prognosis and lacks early diagnostic markers. It is urgent need to explore new biomarkers and prognostic factors. The oxysterol-bind...

    Authors: Kunpeng Tian, Yongling Ying, Jingjing Huang, Hao Wu, Chengyue Wei, Liang Li, Longjun Chen and Lichuan Wu
    Citation: BMC Cancer 2023 23:244
  29. Endometrial carcinoma (EC) is one of the most common gynecological malignancies in China and globally, accounting for the fourth-prevalent cancer in women. Although numerous studies have confirmed prognostic v...

    Authors: Zihui Yang, Xi Yang, Xinyu Liu, Ke Ma, Yi-Ting Meng, Hong-Fang Yin, Jia Wen, Jiang-Hui Yang, Zeng Zhen, Zong-Hao Feng and Qin-Ping Liao
    Citation: BMC Cancer 2023 23:243
  30. Chaperonin-containing tailless complex polypeptide 1 (TCP1) subunit 3 (CCT3) has tumor-promoting effects in lung adenocarcinoma (LUAD). This study aims to investigate the molecular mechanisms of CCT3 in LUAD o...

    Authors: Junfeng Huang, Bingqi Hu, Ying Yang, Huanhuan Liu, Xingyu Fan, Jing Zhou and Liwen Chen
    Citation: BMC Cancer 2023 23:241
  31. Breast cancer has become the most common malignant tumour worldwide. Distant metastasis is one of the leading causes of breast cancer-related death. To verify the performance of clinicomics-guided distant meta...

    Authors: Chao Zhang, Lisha Qi, Jun Cai, Haixiao Wu, Yao Xu, Yile Lin, Zhijun Li, Vladimir P. Chekhonin, Karl Peltzer, Manqing Cao, Zhuming Yin, Xin Wang and Wenjuan Ma
    Citation: BMC Cancer 2023 23:239
  32. Preclinical studies suggest that glucocorticoids (GCs) promote the proliferation and development of colorectal cancer. Because GCs are broadly prescribed for treatment-related adverse events in patients with l...

    Authors: Xiaoxue Huang, Zhiyuan Zheng, Bangwei Zeng, Han Xiao, Hao Zheng, Zhuangbin Lin, Jianyuan Song, Anchuan Li, Pan Chi, Yinghong Yang, Benhua Xu and Rong Zheng
    Citation: BMC Cancer 2023 23:238
  33. At present, there are a variety of antiviral drugs for HBV in clinical practice, but there is no standard scheme for transcatheter arterial chemoembolization(TACE) combined with antiviral drugs. The aim of thi...

    Authors: Haohao Lu, Chuansheng Zheng, Bin Xiong and Xiangwen Xia
    Citation: BMC Cancer 2023 23:235
  34. The T790M mutation is the major resistance mechanism to first- and second-generation TKIs in EGFR-mutant NSCLC. This study aimed to investigate the utility of droplet digital PCR (ddPCR) for detection of T790M...

    Authors: Chun-Ta Huang, Chih-An Lin, Te-Jen Su, Ching-Yao Yang, Tzu-Hsiu Tsai, Chia-Lin Hsu, Wei-Yu Liao, Kuan-Yu Chen, Chao-Chi Ho and Chong-Jen Yu
    Citation: BMC Cancer 2023 23:234
  35. Late detection of hepatocellular carcinoma (HCC) results in an overall 5-year survival rate of less than 16%. Liquid biopsy (LB) assays based on detecting circulating tumor DNA (ctDNA) might provide an opportu...

    Authors: Van-Chu Nguyen, Trong Hieu Nguyen, Thanh Hai Phan, Thanh-Huong Thi Tran, Thu Thuy Thi Pham, Tan Dat Ho, Hue Hanh Thi Nguyen, Minh-Long Duong, Cao Minh Nguyen, Que-Tran Bui Nguyen, Hoai-Phuong Thi Bach, Van-Vu Kim, The-Anh Pham, Bao Toan Nguyen, Thanh Nhan Vo Nguyen, Le Anh Khoa Huynh…
    Citation: BMC Cancer 2023 23:233
  36. Germ cell tumors are relatively common in young men. They derive from a non-invasive precursor, called germ cell neoplasia in situ, but the exact pathogenesis is still unknown. Thus, further understanding prov...

    Authors: Birte Schulz, Valérie Schumacher, Anaclet Ngezahayo, Daniela Maier-Begandt, Nadine Schadzek, Jochen Wilhelm, Wolfgang Weidner, Adrian Pilatz, Daniela Fietz, Sabine Kliesch, Nadine Schnepel, Nina Hambruch, Kristina Rode, Marion Langeheine and Ralph Brehm
    Citation: BMC Cancer 2023 23:232
  37. Dose reduction of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukaemia (CML) with an optimal response to TKIs may support cost-effective medication use by maintaining therapeutic effecti...

    Authors: Melissa F Djodikromo, Rosella PMG Hermens, Bart JF van den Bemt, Yolba Smit, Tim M Govers, Charlotte L Bekker and Nicole MA Blijlevens
    Citation: BMC Cancer 2023 23:231
  38. An early diagnosis of pancreatic cancer (PC) is extremely difficult because of the lack of sensitive liquid biopsy methods and effective biomarkers. We attempted to evaluate whether circulating inflammatory ma...

    Authors: Yuanlong Gu, Qianjin Hua, Zhipeng Li, Xingli Zhang, Changjie Lou, Yangfen Zhang, Wei Wang, Peiyuan Cai and Juan Zhao
    Citation: BMC Cancer 2023 23:227

Featured videos

View featured videos from across the BMC-series journals